---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-21-004239"
form_type: "8-K"
ticker: "CNBX"
cik: "0001343009"
company_name: "CNBX Pharmaceuticals Inc."
filed_at: "2021-09-13T23:59:59+00:00"
generated_at: "2026-06-29T04:06:51.365292+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cannabics Pharmaceuticals appoints Gabriel Yariv as Executive Chairman

## Summary
- Gabriel Yariv appointed as Executive Chairman effective September 3, 2021.
- Yariv brings over 20 years experience in medical industry; co-founded BreathID (now Medtronic) and SimuTec.
- Yariv will continue as Director and Chief Operational Executive while serving as Executive Chair.
- Appointment made by unanimous board resolution on September 3, 2021.

## SEC filing metadata
- accession: 0001683168-21-004239
- form_type: 8-K
- ticker: CNBX
- cik: 0001343009
- company_name: CNBX Pharmaceuticals Inc.
- filed_at: 2021-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1343009/000168316821004239/0001683168-21-004239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1343009/000168316821004239/cannabics_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-21-004239
- JSON: https://secwatch.observer/filing/0001683168-21-004239.json
- Plain text: https://secwatch.observer/filing/0001683168-21-004239.txt

## Key facts
- Executive change
  Gabriel Yariv was appointed as Executive Chairman at CNBX Pharmaceuticals Inc..
  - Action: nominated
  - Role: Executive Chairman
  source text: On September 5 rd , 2021, the Board of Directors nominated fellow Director Mr. Gabriel Yariv as Executive Chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1343009/000168316821004239/0001683168-21-004239-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.